News bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Delayed Nasdaq Other stock markets 10:58:41 03/05/2024 pm IST			5-day change	1st Jan Change
2.145 ^USD	-6.32%		-10.97%	+43.49%

01/04	BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
20/03	BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioAffinity Technologies News Update	02/05	BU
BioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth	24/04	BU
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening	09/04	BU
BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02/04	CI
BioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results	01/04	BU
BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding	20/03	CI
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	11/03	AQ
BioAffinity Technologies Closes $2.5 Million Equity Offerings	09/03	MT
Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	08/03	PR
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	08/03	BU
WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement	06/03	PR
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	06/03	BU
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath Lung	06/03	AQ
BioAffinity Technologies, Inc. announced that it expects to receive $2.624 million in funding	06/03	CI
BioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung	05/03	BU
BioAffinity Technologies News Update	21/02	BU
Medical Director of Pennsylvania's Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies Medical and Scientific Advisory Board and Incorporates CyPath Lung into Medical Practice	07/02	AQ
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice	06/02	BU
BioAffinity Technologies, Inc. Appoints Sandeep Bansal to Medical and Scientific Advisory Board	06/02	CI
BioAffinity Technologies In The News	30/01	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Summary

Filters